Cargando…

Arterial access-site complications after use of a vascular closure device related to puncture height

BACKGROUND: To analyze differences of access-site complications related to the height of femoral arterial puncture and the use of a vascular closure device (VCD) following percutaneous coronary intervention (PCI). METHODS: A subgroup of the FERARI study being treated by femoral arterial access and v...

Descripción completa

Detalles Bibliográficos
Autores principales: Sartorius, Benjamin, Behnes, Michael, Ünsal, Melike, Hoffmann, Ursula, Lang, Siegfried, Mashayekhi, Kambis, Borggrefe, Martin, Akin, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314616/
https://www.ncbi.nlm.nih.gov/pubmed/28209184
http://dx.doi.org/10.1186/s12872-017-0484-7
_version_ 1782508552009547776
author Sartorius, Benjamin
Behnes, Michael
Ünsal, Melike
Hoffmann, Ursula
Lang, Siegfried
Mashayekhi, Kambis
Borggrefe, Martin
Akin, Ibrahim
author_facet Sartorius, Benjamin
Behnes, Michael
Ünsal, Melike
Hoffmann, Ursula
Lang, Siegfried
Mashayekhi, Kambis
Borggrefe, Martin
Akin, Ibrahim
author_sort Sartorius, Benjamin
collection PubMed
description BACKGROUND: To analyze differences of access-site complications related to the height of femoral arterial puncture and the use of a vascular closure device (VCD) following percutaneous coronary intervention (PCI). METHODS: A subgroup of the FERARI study being treated by femoral arterial access and valuable inguinal angiography before implantation of a VCD were included. Inguinal angiographies were systematically reviewed by two independent cardiologists to determine the correct height of femoral arterial puncture. Bleeding complications were documented within 30 days after PCI and were categorized according to BARC, TIMI, GUSTO and FERARI classifications. RESULTS: Femoral access point imaging was available in 95 patients compared to 105 patients without. The common femoral artery (CFA) was the most accessed artery in 41%, followed by the femoral arterial bifurcation (39%) and lower access sites distally from the femoral arterial bifurcation (low puncture: 20%). No differences were observed regarding indication of PCI, procedural data and anticoagulation therapies in relation to the heights of femoral arterial access (p > 0.05). Despite using VCD, arterial puncture at the CFA resulted in numerically highest numbers of overall bleedings (62%) compared to femoral arterial bifurcation (41%) (p = 0.059). 58% of bleedings occurred after arterial puncture below the femoral bifurcation (low puncture). Though no significant differences of bleedings regarding classifications of BARC, GUSTO, TIMI and FERARI as well as other vascular endpoints were observed regarding puncture height. CONCLUSIONS: The present analysis demonstrates no significant differences of bleeding complications in relation to the height of femoral arterial puncture and subsequent use of a VCD.
format Online
Article
Text
id pubmed-5314616
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53146162017-02-24 Arterial access-site complications after use of a vascular closure device related to puncture height Sartorius, Benjamin Behnes, Michael Ünsal, Melike Hoffmann, Ursula Lang, Siegfried Mashayekhi, Kambis Borggrefe, Martin Akin, Ibrahim BMC Cardiovasc Disord Research Article BACKGROUND: To analyze differences of access-site complications related to the height of femoral arterial puncture and the use of a vascular closure device (VCD) following percutaneous coronary intervention (PCI). METHODS: A subgroup of the FERARI study being treated by femoral arterial access and valuable inguinal angiography before implantation of a VCD were included. Inguinal angiographies were systematically reviewed by two independent cardiologists to determine the correct height of femoral arterial puncture. Bleeding complications were documented within 30 days after PCI and were categorized according to BARC, TIMI, GUSTO and FERARI classifications. RESULTS: Femoral access point imaging was available in 95 patients compared to 105 patients without. The common femoral artery (CFA) was the most accessed artery in 41%, followed by the femoral arterial bifurcation (39%) and lower access sites distally from the femoral arterial bifurcation (low puncture: 20%). No differences were observed regarding indication of PCI, procedural data and anticoagulation therapies in relation to the heights of femoral arterial access (p > 0.05). Despite using VCD, arterial puncture at the CFA resulted in numerically highest numbers of overall bleedings (62%) compared to femoral arterial bifurcation (41%) (p = 0.059). 58% of bleedings occurred after arterial puncture below the femoral bifurcation (low puncture). Though no significant differences of bleedings regarding classifications of BARC, GUSTO, TIMI and FERARI as well as other vascular endpoints were observed regarding puncture height. CONCLUSIONS: The present analysis demonstrates no significant differences of bleeding complications in relation to the height of femoral arterial puncture and subsequent use of a VCD. BioMed Central 2017-02-16 /pmc/articles/PMC5314616/ /pubmed/28209184 http://dx.doi.org/10.1186/s12872-017-0484-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sartorius, Benjamin
Behnes, Michael
Ünsal, Melike
Hoffmann, Ursula
Lang, Siegfried
Mashayekhi, Kambis
Borggrefe, Martin
Akin, Ibrahim
Arterial access-site complications after use of a vascular closure device related to puncture height
title Arterial access-site complications after use of a vascular closure device related to puncture height
title_full Arterial access-site complications after use of a vascular closure device related to puncture height
title_fullStr Arterial access-site complications after use of a vascular closure device related to puncture height
title_full_unstemmed Arterial access-site complications after use of a vascular closure device related to puncture height
title_short Arterial access-site complications after use of a vascular closure device related to puncture height
title_sort arterial access-site complications after use of a vascular closure device related to puncture height
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314616/
https://www.ncbi.nlm.nih.gov/pubmed/28209184
http://dx.doi.org/10.1186/s12872-017-0484-7
work_keys_str_mv AT sartoriusbenjamin arterialaccesssitecomplicationsafteruseofavascularclosuredevicerelatedtopunctureheight
AT behnesmichael arterialaccesssitecomplicationsafteruseofavascularclosuredevicerelatedtopunctureheight
AT unsalmelike arterialaccesssitecomplicationsafteruseofavascularclosuredevicerelatedtopunctureheight
AT hoffmannursula arterialaccesssitecomplicationsafteruseofavascularclosuredevicerelatedtopunctureheight
AT langsiegfried arterialaccesssitecomplicationsafteruseofavascularclosuredevicerelatedtopunctureheight
AT mashayekhikambis arterialaccesssitecomplicationsafteruseofavascularclosuredevicerelatedtopunctureheight
AT borggrefemartin arterialaccesssitecomplicationsafteruseofavascularclosuredevicerelatedtopunctureheight
AT akinibrahim arterialaccesssitecomplicationsafteruseofavascularclosuredevicerelatedtopunctureheight